Replies to post #12323 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Who knows, but as Sherlock likes to say "Once you eliminate the impossible, whatever remains, no matter how improbable, must be the truth."

It's impossible that Titan is developing its own peripherally acting Kappa opioid receptor agonist...they don't research drugs, just the application of drugs through pro neura.

Cara Therapeutics states: Cara Therapeutics is developing the first peripherally acting kappa opioid receptor agonist (KORA) called CR845.

So if this is really "the first" peripherally acting Kappa opioid receptor agonist, and it's only in preclinical development, is it impossible for Titan to be working with anyone else?